Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges

Journal:

The New England Journal of Medicine

Published:

2026-02-19

DOI:

10.1056/nejmoa2508228

Affiliations:

20

Authors:

36

Go to article

Institutions	Authors	Share
ViiV Healthcare Company USA, United States of America (USA)	4.500000	0.13
UCLA Health, United States of America (USA)	4.000000	0.11
National Institutes of Health (NIH), United States of America (USA)	4.000000	0.11
The University of Alabama at Birmingham (UAB), United States of America (USA)	3.000000	0.08
University of Colorado Anschutz Medical Campus (CU Anschutz), United States of America (USA)	2.500000	0.07
The University of Texas Health Science Center at Houston (UTHealth), United States of America (USA)	2.000000	0.06
Frontier Science Foundation, United States of America (USA)	2.000000	0.06
Harvard University, United States of America (USA)	2.000000	0.06
Brown University, United States of America (USA)	2.000000	0.06
Johnson & Johnson, Belgium, Belgium	2.000000	0.06
University of Rochester (UR), United States of America (USA)	1.000000	0.03
University of Cincinnati (UC), United States of America (USA)	1.000000	0.03
NIH National Institute of Allergy and Infectious Diseases (NIAID), United States of America (USA)	1.000000	0.03
The University of North Carolina at Chapel Hill (UNC), United States of America (USA)	1.000000	0.03
NIH National Institute of Mental Health (NIMH), United States of America (USA)	1.000000	0.03
Rush University Medical Center, United States of America (USA)	1.000000	0.03
Brigham and Women's Hospital (BWH), United States of America (USA)	1.000000	0.03
DLH, United States of America (USA)	0.500000	0.01
AIDS Clinical Trials Group (ACTG), United States of America (USA)	0.500000	0.01

Interested in Clinical Sciences?